[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100456072":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":21,"centralContacts":26,"locations":35,"responsibleParty":60,"collaborators":20,"id":62,"slug":63,"hasResults":64,"nctId":65,"briefTitle":66,"officialTitle":67,"acronym":68,"eligibilityCriteria":69,"healthyVolunteers":64,"sex":70,"minAge":71,"maxAge":72,"enrollmentInfo":73,"targetDuration":20,"studyType":76,"phases":77,"briefSummary":79,"conditions":80,"keywords":20,"overallStatus":38,"whyStopped":20,"lastUpdateSubmitDate":82,"lastUpdatePostDateStruct":83,"startDateStruct":86,"completionDateStruct":88,"leadSponsor":90,"locationsCount":91},{"fullName":5,"class":6},"Urological Research Network, LLC","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Treatment group","EXPERIMENTAL","Patients underwent Cryotheapy assisted partial nephrectomy",[13],"Device: Cryoablation Assisted Partial Nephrectomy",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":20},"DEVICE","Cryoablation Assisted Partial Nephrectomy","Cryoablation Assisted Partial Nephrectomy is monitored under Ultrasound guidance, A Cryoablation machine (FDA Approved Device) along with its Cryoprobes are used in the study The Cryoprobes are placed in close to the endophytic tumor margins. The tumor boundary area will undergo one freezing cycles. Tumor is excised after 5 minutes of freezing cycle. Thawing process is passive, renal defect repair is conducted during thawing process.",[9],null,[22],{"name":23,"affiliation":24,"role":25},"Fernando J Bianco, MD","Urological research Network","PRINCIPAL_INVESTIGATOR",[27,32],{"name":28,"role":29,"phone":30,"phoneExt":20,"email":31},"Eusebio J Luna, MD","CONTACT","3058227227","drluna@research.surgery",{"name":33,"role":29,"phone":30,"phoneExt":20,"email":34},"Cielo Guerra","cielo@besturology.net",[36],{"facility":37,"status":38,"city":39,"state":40,"zip":41,"country":42,"countryCode":43,"cosmosGeoPoint":44,"geoPoint":49,"contacts":50},"Urological Research Network","RECRUITING","Miami Lakes","Florida","33016","United States","US",{"type":45,"coordinates":46},"Point",[47,48],-80.30866,25.90871,{"lat":48,"lon":47},[51,55,57],{"name":52,"role":29,"phone":53,"phoneExt":20,"email":54},"CIELO GUERRA, BS","305-515-9887","CIELO@BESTUROLOGY.NET",{"name":56,"role":25,"phone":20,"phoneExt":20,"email":20},"FERNANDO J BIANCO, MD",{"name":58,"role":59,"phone":20,"phoneExt":20,"email":20},"EUSEBIO J LUNA, MD","SUB_INVESTIGATOR",{"type":61,"investigatorFullName":20,"investigatorTitle":20,"investigatorAffiliation":20,"oldNameTitle":20,"oldOrganization":20},"SPONSOR","100456072","cryaoablation-assisted-partial-nephrectomy-a-non-ischemic-approach-100456072",false,"NCT05218811","Cryaoablation Assisted Partial Nephrectomy a Non Ischemic Approach","Cryotherapy and Robotic Assisted Non Ischemic Nephron Sparring Surgery","RCAPN","Inclusion Criteria:\n\n* Patients with ages between 45-90-year-old.\n* Renal tumor ≤ 7 cm in the greatest extension, \\>50% exophitic.\n\nExclusion Criteria:\n\n* Prior renal surgery\n* M1 Disease","ALL","55 Years","65 Years",{"count":74,"type":75},150,"ESTIMATED","INTERVENTIONAL",[78],"NA","Patients with renal masses eligible to partial nephrectomy often require arterial ischemia to control or prevent blood loss during this surgical procedure. This study aims to determine the safety and efficacy of renal cryoablation at the tumor bed, as a substitute measure or technique vs total or selective arterial renal ischemia.",[81],"Kidney Neoplasms","2023-01-24",{"date":84,"type":85},"2023-01-26","ACTUAL",{"date":87,"type":85},"2020-05-15",{"date":89,"type":75},"2041-05-15",{"name":5,"class":6},1]